Status:
COMPLETED
tDCS on Working Memory (WM) in Adults With ASD
Lead Sponsor:
NHS Greater Glasgow and Clyde
Collaborating Sponsors:
University of Glasgow
Conditions:
Autism Spectrum Disorder
Eligibility:
MALE
18-35 years
Phase:
NA
Brief Summary
This study will involve an experiment in individuals with Autism Spectrum Disorder (ASD) comparing their performance on a working memory task before, during and after non-invasive brain stimulation (t...
Detailed Description
Many studies have examined working memory in people with autism spectrum disorder as working memory deficits in individuals with autism spectrum disorder leads to multiple difficulties associated with...
Eligibility Criteria
Inclusion
- clinical diagnosis of ASD
- right handed
- speaks English fluently
- normal vision or corrected to normal
- passing tDCS safety screening
Exclusion
- participants who do not understand verbal or written English (i.e would be in need of translators)
- participants that have ever suffered from epilepsy, febrile convulsions in infancy or had recurrent fainting spells
- family history of epilepsy
- has a heart pacemaker, cochlear implant, medication pump, surgical clips
- has drunk more than 3 units of alcohol in the last 24 hours
- suffers from migraines
- metal in the head, implanted brain medical devices
- has undergone a neurosurgical procedure
- has had more than one cup of coffee, or other sources of caffeine in the last hour
- taking any unprescribed or prescribed medication that might effect tDCS
- medications or psychoactive drugs that can lower seizure threshold \[imipramine, amitriptyline, doxepine, nortriptyline, maprotiline, chlorpromazine, clozapine, foscarnet, ganciclovir, ritonavir, amphetamines, cocaine, (MDMA, ecstasy), phencyclidine (PCP, angel dust), ketamine, gamma-hydroxybutyrate (GHB), alcohol, theophylline\]
- withdrawal from alcohol, barbiturates, benzodiazepines, meprobamate, chloral hydrate
Key Trial Info
Start Date :
February 26 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 21 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03255837
Start Date
February 26 2018
End Date
December 21 2018
Last Update
January 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Glasgow
Glasgow, United Kingdom